Breztri Aerosphere (budesonide/glycopyrrolate/formoterol fumarate) can cause side effects that range from mild to serious. If side effects from Breztri become ...

One of these new inhalers is called Breztri Aerosphere. You may hear this called “triple therapy.” COPD is a long-term (or chronic) condition of the lungs that can make it hard to breathe.

Sharon Barr, Executive Vice President, BioPharmaceuticals R&D, AstraZeneca, said: “We are excited by the positive results from the KALOS and LOGOS trials, which demonstrate that BREZTRI could ...

AstraZeneca (AZN) said on Friday that it received positive results from two late-stage trials for its triple-combination therapy Breztri Aerosphere in patients with uncontrolled asthma.

If you are worried about using this medicine, speak to your doctor or pharmacist. BREZTRI AEROSPHERE contains three active ingredients in the one puffer: budesonide, glycopyrronium, and formoterol ...

AstraZeneca will present full data at an upcoming meeting. Breztri Aerosphere, a triple inhaled therapy, met its primary endpoint of lung function improvement in adults and adolescents with ...

Breztri is an inhaled triple-combination therapy approved for chronic obstructive pulmonary disease (COPD) in adults in more than 80 countries worldwide, including the US, EU, China, and Japan.

May 2 (Reuters) - AstraZeneca (AZN.L), opens new tab said on Friday its triple-combination inhaler Breztri Aerosphere met all main goals in two late-stage trials for uncontrolled asthma ...

WILMINGTON, Del., May 02, 2025--(BUSINESS WIRE)--Positive high-level results from the Phase III KALOS and LOGOS trials in patients with uncontrolled asthma showed that AstraZeneca’s fixed-dose ...

KALOS and LOGOS were replicate, randomized, double-blind trials designed to investigate BREZTRI as a potential treatment for asthma.1,2 The trials evaluated the efficacy and safety of BREZTRI ...

Positive high-level results from the Phase III KALOS and LOGOS trials in patients with uncontrolled asthma showed that AstraZeneca’s fixed-dose triple-combination therapy BREZTRI AEROSPHERE ...